1 Donelli MG, "Pharmacokinetics of anticancer agents in patients with impaired liver function" 34 : 33-46, 1998
2 Nand S, "Neurotoxicity associated with systemic high-dose cytosine arabinoside" 4 : 571-575, 1986
3 Verstappen CC, "Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management" 63 : 1549-1563, 2003
4 Hasle H, "Cerebellar toxicity during cytarabine therapy associated with renal insufficiency" 27 : 76-78, 1990
5 Winkelman MD, "Cerebellar degeneration caused by high-dose cytosine arabinoside: a clinicopathological study" 14 : 520-527, 1983
6 Miller L, "Cerebellar atrophy caused by high-dose cytosine arabinoside: CT and MR findings" 152 : 343-344, 1989
7 Lazarus HM, "Central nervous system toxicity of high-dose systemic cytosine arabinoside" 48 : 2577-2582, 1981
8 Aldoss IT, "Adult Burkitt lymphoma: advances in diagnosis and treatment" 22 : 1508-1517, 2008
1 Donelli MG, "Pharmacokinetics of anticancer agents in patients with impaired liver function" 34 : 33-46, 1998
2 Nand S, "Neurotoxicity associated with systemic high-dose cytosine arabinoside" 4 : 571-575, 1986
3 Verstappen CC, "Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management" 63 : 1549-1563, 2003
4 Hasle H, "Cerebellar toxicity during cytarabine therapy associated with renal insufficiency" 27 : 76-78, 1990
5 Winkelman MD, "Cerebellar degeneration caused by high-dose cytosine arabinoside: a clinicopathological study" 14 : 520-527, 1983
6 Miller L, "Cerebellar atrophy caused by high-dose cytosine arabinoside: CT and MR findings" 152 : 343-344, 1989
7 Lazarus HM, "Central nervous system toxicity of high-dose systemic cytosine arabinoside" 48 : 2577-2582, 1981
8 Aldoss IT, "Adult Burkitt lymphoma: advances in diagnosis and treatment" 22 : 1508-1517, 2008